Magnetar Financial LLC Invests $859,000 in Ryan Specialty Holdings, Inc. (NYSE:RYAN)

Magnetar Financial LLC acquired a new stake in Ryan Specialty Holdings, Inc. (NYSE:RYAN - Free Report) in the 4th quarter, according to the company in its most recent filing with the SEC. The firm acquired 13,394 shares of the company's stock, valued at approximately $859,000.

Several other hedge funds have also recently modified their holdings of RYAN. Raymond James Financial Inc. bought a new position in Ryan Specialty during the fourth quarter valued at $94,484,000. Principal Financial Group Inc. boosted its position in shares of Ryan Specialty by 115.2% during the 4th quarter. Principal Financial Group Inc. now owns 1,833,209 shares of the company's stock valued at $117,619,000 after acquiring an additional 981,505 shares during the last quarter. Eagle Asset Management Inc. increased its position in shares of Ryan Specialty by 32.1% in the third quarter. Eagle Asset Management Inc. now owns 1,380,510 shares of the company's stock worth $98,555,000 after purchasing an additional 335,180 shares during the last quarter. Charles Schwab Investment Management Inc. lifted its stake in Ryan Specialty by 43.9% during the third quarter. Charles Schwab Investment Management Inc. now owns 938,187 shares of the company's stock worth $62,286,000 after purchasing an additional 286,380 shares during the last quarter. Finally, JPMorgan Chase & Co. boosted its holdings in shares of Ryan Specialty by 107.5% in the 3rd quarter. JPMorgan Chase & Co. now owns 459,464 shares of the company's stock worth $30,504,000 after purchasing an additional 238,064 shares in the last quarter. Institutional investors own 84.82% of the company's stock.

Ryan Specialty Trading Down 1.4 %

Shares of Ryan Specialty stock traded down $1.04 during midday trading on Wednesday, reaching $71.49. 557,213 shares of the company's stock traded hands, compared to its average volume of 908,724. The stock has a 50 day moving average of $68.39 and a 200-day moving average of $68.13. Ryan Specialty Holdings, Inc. has a 12 month low of $48.48 and a 12 month high of $75.97. The company has a market cap of $18.72 billion, a PE ratio of 103.61, a price-to-earnings-growth ratio of 1.19 and a beta of 0.71. The company has a debt-to-equity ratio of 2.40, a quick ratio of 1.01 and a current ratio of 1.01.

Ryan Specialty (NYSE:RYAN - Get Free Report) last posted its earnings results on Thursday, February 20th. The company reported $0.45 EPS for the quarter, missing the consensus estimate of $0.47 by ($0.02). Ryan Specialty had a return on equity of 48.01% and a net margin of 9.14%. The company had revenue of $663.53 million during the quarter, compared to analysts' expectations of $658.80 million. As a group, equities analysts expect that Ryan Specialty Holdings, Inc. will post 2.29 EPS for the current fiscal year.

Ryan Specialty Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Tuesday, March 4th were given a dividend of $0.12 per share. This represents a $0.48 annualized dividend and a yield of 0.67%. This is a boost from Ryan Specialty's previous quarterly dividend of $0.11. The ex-dividend date was Tuesday, March 4th. Ryan Specialty's payout ratio is presently 69.57%.

Insiders Place Their Bets

In other news, EVP Brendan Martin Mulshine sold 30,000 shares of the company's stock in a transaction dated Friday, March 14th. The shares were sold at an average price of $69.30, for a total value of $2,079,000.00. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, Director Nicholas Dominic Cortezi sold 35,000 shares of the stock in a transaction dated Wednesday, January 15th. The stock was sold at an average price of $65.99, for a total transaction of $2,309,650.00. Following the completion of the transaction, the director now owns 35,609 shares of the company's stock, valued at approximately $2,349,837.91. The trade was a 49.57 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders have sold 241,360 shares of company stock worth $16,006,428. Company insiders own 11.10% of the company's stock.

Analysts Set New Price Targets

A number of research firms recently weighed in on RYAN. Keefe, Bruyette & Woods dropped their target price on Ryan Specialty from $77.00 to $76.00 and set an "outperform" rating for the company in a research report on Friday, February 21st. Royal Bank of Canada lowered their price objective on shares of Ryan Specialty from $73.00 to $72.00 and set a "sector perform" rating for the company in a report on Friday, February 21st. UBS Group lifted their target price on shares of Ryan Specialty from $82.00 to $84.00 and gave the stock a "buy" rating in a research report on Wednesday, February 26th. Wells Fargo & Company upped their price target on shares of Ryan Specialty from $64.00 to $69.00 and gave the company an "equal weight" rating in a research report on Friday, February 21st. Finally, Morgan Stanley assumed coverage on Ryan Specialty in a report on Thursday, December 5th. They issued an "overweight" rating and a $90.00 price objective on the stock. One equities research analyst has rated the stock with a sell rating, six have given a hold rating and six have assigned a buy rating to the stock. According to data from MarketBeat, Ryan Specialty presently has an average rating of "Hold" and a consensus target price of $75.27.

Ryan Specialty Company Profile

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.